Lack of efficacy of long-term, low-dose azithromycin in chronic rhinosinusitis: A randomized controlled trial

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 66, Issue 11, 2011, Pages 1457-1468

  Videler, W J ^a   Badia, L ^b   Harvey, R J ^b,c   Gane, S ^b   Georgalas, C ^a   Van Der Meulen, F W ^a   Menger, D J ^a   Lehtonen, M T ^d   Toppila Salmi, S K ^d   Vento, S I ^e   Hytonen M ^e   Hellings, P W ^f   Kalogjera, L ^g   Lund, V J ^b   Scadding, G ^b   Mullol, J ^h   Fokkens, W J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b ROYAL NATIONAL THROAT NOSE AND EAR HOSPITAL   (United Kingdom)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d TAMPERE UNIVERSITY HOSPITAL   (Finland)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^f UNIVERSITY OF LEUVEN   (Belgium)

^g SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^h HOSPITAL CLÍNIC   (Spain)

Author keywords

antibiotic treatment; azithromycin; chronic rhinosinusitis; long term low dose; nasal polyps; nose diseases; oral administration; paranasal sinus diseases; randomized controlled trial; sinusitis

Indexed keywords

AZITHROMYCIN; PLACEBO;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; ASTHMA; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG WITHDRAWAL; ENDOSCOPY; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NOSE POLYP; PATIENT MONITORING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RHINOSINUSITIS; SCORING SYSTEM; SENSORY ANALYSIS; SHORT FORM 36; SINO NASAL OUTCOME TEST 22; TREATMENT RESPONSE; VISUAL ANALOG SCALE;

ADULT; AGED; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CHRONIC DISEASE; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; ENDOSCOPY; FEMALE; HUMANS; MACROLIDES; MALE; MIDDLE AGED; RHINITIS; SINUSITIS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 80053938774     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2011.02693.x     Document Type: Article

References (48)

1. Fokkens W, Lund V, Mullol J,. European position paper on rhinosinusitis and nasal polyps 2007. Rhinol Suppl 2007; 20: 1-136.
2. Levine HL,. Functional endoscopic sinus surgery: evaluation, surgery, and follow-up of 250 patients. Laryngoscope 1990; 100: 79-84. (Pubitemid 20020502)
3. Agius AM,. Long-term follow-up of patients with facial pain in chronic rhinosinusitis-correlation with nasal endoscopy and CT. Rhinology 2010; 48: 65-70.
4. Ragab SM, Lund VJ, Scadding G, Saleh HA, Khalifa MA,. Impact of chronic rhinosinusitis therapy on quality of life: a prospective randomized controlled trial. Rhinology 2010; 48: 305-311.
5. Hopkins C, Slack R, Lund V, Brown P, Copley L, Browne J,. Long-term outcomes from the English national comparative audit of surgery for nasal polyposis and chronic rhinosinusitis. Laryngoscope 2009; 119: 2459-2465.
6. Senior BA, Kennedy DW,. Long-term results of functional endoscopic sinus surgery. Laryngoscope 1998; 108: 151-157. (Pubitemid 28128200)
7. Omura S,. Macrolide antibiotics; chemistry, biology and practice, 2nd edn. Amsterdam; Boston: Academic Press, 2002.
8. Tamaoki J,. The effects of macrolides on inflammatory cells. Chest 2004; 125 (2 Suppl.): 41S-50S.
9. Hashiba M, Baba S,. Efficacy of long-term administration of clarithromycin in the treatment of intractable chronic sinusitis. Acta Otolaryngol Suppl 1996; 525: 73-78. (Pubitemid 26332367)
10. Ichimura K, Shimazaki Y, Ishibashi T, Higo R,. Effect of new macrolide roxithromycin upon nasal polyps associated with chronic sinusitis. Auris Nasus Larynx 1996; 23: 48-56. (Pubitemid 26185193)
11. Elmorsy S, El-Naggar MM, Abdel aal SM, Abou-elela MA,. Sinus aspirates in chronic rhinosinusitis: fungal colonization of paranasal sinuses, evaluation of ICAM-1 and IL-8 and studying of immunological effect of long-term macrolide therapy. Rhinology 2010; 48: 312-317.
12. Cervin A, Kalm O, Sandkull P, Lindberg S,. One-year low-dose erythromycin treatment of persistent chronic sinusitis after sinus surgery: clinical outcome and effects on mucociliary parameters and nasal nitric oxide. Otolaryngol Head Neck Surg 2002; 126: 481-489. (Pubitemid 41123534)
13. Ragab SM, Lund VJ, Scadding G,. Evaluation of the medical and surgical treatment of chronic rhinosinusitis: a prospective, randomised, controlled trial. Laryngoscope 2004; 114: 923-930. (Pubitemid 38625551)
14. Wallwork B, Coman W, Mackay-Sim A, Greiff L, Cervin A,. A double-blind, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis. Laryngoscope 2006; 116: 189-193. (Pubitemid 44383921)
15. van Zele T, Gevaert P, Holtappels G, Beule A, Wormald PJ, Mayr S, et al., Oral steroids and doxycycline: two different approaches to treat nasal polyps. J Allergy Clin Immunol 2010; 125: 1069-1076.
16. Lund VJ, Mackay IS,. Staging in rhinosinusitus. Rhinology 1993; 31: 183-184. (Pubitemid 24049736)
17. Foulds G, Shepard RM, Johnson RB,. The pharmacokinetics of azithromycin in human serum and tissues. J Antimicrob Chemother 1990; 25 (Suppl A): 73-82. (Pubitemid 20043952)
18. Gladue RP, Bright GM, Isaacson RE, Newborg MF,. In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection. Antimicrob Agents Chemother 1989; 33: 277-282. (Pubitemid 19071957)
19. Karma P, Pukander J, Penttila M,. Azithromycin concentrations in sinus fluid and mucosa after oral administration. Eur J Clin Microbiol Infect Dis 1991; 10: 856-859.
20. Hoepelman IM, Schneider MM,. Azithromycin: the first of the tissue-selective azalides. Int J Antimicrob Agents 1995; 5: 145-167.
21. Nahata MC, Koranyi KI, Luke DR, Foulds G,. Pharmacokinetics of azithromycin in pediatric patients with acute otitis media. Antimicrob Agents Chemother 1995; 39: 1875-1877.
22. Marchisio P, Principi N, Sala E, Lanzoni L, Sorella S, Massimini A,. Comparative study of once-weekly azithromycin and once-daily amoxicillin treatments in prevention of recurrent acute otitis media in children. Antimicrob Agents Chemother 1996; 40: 2732-2736. (Pubitemid 26404334)
23. Schmedes A, Lildholdt T, Schouenborg P, Eriksen DW,. Azithromycin concentrations and microbiology of tonsils during weekly medication in patients with recurrent tonsillitis. Clin Drug Investig 1998; 15: 467-472. (Pubitemid 28288630)
24. Leopold D, Ferguson BJ, Piccirillo JF,. Outcomes assessment. Otolaryngol Head Neck Surg 1997; 117 (3 Pt 2): S58-S68. (Pubitemid 27435431)
25. Hopkins C, Gillett S, Slack R, Lund VJ, Browne JP,. Psychometric validity of the 22-item sinonasal outcome test. Clin Otolaryngol 2009; 34: 447-454.
26. Ware JE, Sherbourne CD,. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473-483.
27. Aaronson NK, Acquadro C, Alonso J, et al., International quality of life assessment (IQOLA) project. Qual Life Res 1992; 1: 349-351.
28. van Oene CM, van Reij EJ, Sprangers MA, Fokkens WJ,. Quality-assessment of disease-specific quality of life questionnaires for rhinitis and rhinosinusitis: a systematic review. Allergy 2007; 62: 1359-1371. (Pubitemid 350045584)
29. Alobid I, Bernal-Sprekelsen M, Mullol J,. Chronic rhinosinusitis and nasal polyps: the role of generic and specific questionnaires on assessing its impact on patient's quality of life. Allergy 2008; 63: 1267-1279.
30. Ottaviano G, Scadding GK, Coles S, Lund VJ,. Peak nasal inspiratory flow; normal range in adult population. Rhinology 2006; 44: 32-35. (Pubitemid 43379714)
31. Hummel T, Kobal G, Gudziol H, Mackay-Sim A,. Normative data for the "Sniffin' Sticks" including tests of odor identification, odor discrimination, and olfactory thresholds: an upgrade based on a group of more than 3,000 subjects. Eur J Clin Microbiol Infect Dis 2007; 264: 237-243. (Pubitemid 46214098)
32. Suzuki H, Shimomura A, Ikeda K, Furukawa M, Oshima T, Takasaka T,. Inhibitory effect of macrolides on interleukin-8 secretion from cultured human nasal epithelial cells. Laryngoscope 1997; 107 (12 Pt 1): 1661-1666. (Pubitemid 27520179)
33. Kohyama T, Takizawa H, Kawasaki S, Akiyama N, Sato M, Ito K,. Fourteen-member macrolides inhibit interleukin-8 release by human eosinophils from atopic donors. Antimicrob Agents Chemother 1999; 43: 907-911. (Pubitemid 29165756)
34. Wallwork B, Coman W, Feron F, Mackay-Sim A, Cervin A,. Clarithromycin and prednisolone inhibit cytokine production in chronic rhinosinusitis. Laryngoscope 2002; 112: 1827-1830.
35. Saiman L, Anstead M, Mayer-Hamblett N, Lands LC, Kloster M, Hocevar-Trnka J, et al., Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial. JAMA 2010; 303: 1707-1715.
36. Miyanohara T, Ushikai M, Matsune S, Ueno K, Katahira S, Kurono Y,. Effects of clarithromycin on cultured human nasal epithelial cells and fibroblasts. Laryngoscope 2000; 110: 126-131. (Pubitemid 30046658)
37. Nonaka M, Pawankar R, Saji F, Yagi T,. Effect of roxithromycin on IL-8 synthesis and proliferation of nasal polyp fibroblasts. Acta Otolaryngol Suppl 1998; 539: 5.
38. Cervin A,. The anti-inflammatory effect of erythromycin and its derivatives, with special reference to nasal polyposis and chronic sinusitis. Acta Otolaryngol 2001; 121: 83-92. (Pubitemid 32205030)
39. Scadding GK, Lund VJ, Darby YC,. The effect of long-term antibiotic therapy upon ciliary beat frequency in chronic rhinosinusitis. J Laryngol Otol 1995; 109: 24-26.
40. Sofer D, Gilboa-Gaber N, Belz A, Garber NC,. Subinhibitory erythromycin represses production of Pseudomonas aeruginosa lectins, autoinducer and virulence factors. Chemotherapy 1999; 45: 335-341. (Pubitemid 29410812)
41. Fokkens WJ,. Recalcitrant rhinosinusitis, the diagnosis and treatment and evaluation of results. Rhinology 2010; 48: 257-258.
42. Gray GC, McPhate DC, Leinonen M, Cassell GH, Deperalta EP, Putnam SD, et al., Weekly oral azithromycin as prophylaxis for agents causing acute respiratory disease. Clin Infect Dis 1998; 26: 103-110. (Pubitemid 28068162)
43. Skerk V, Krhen I, Lisic M, Begovac J, Roglic S, Skerk V, et al., Comparative randomized pilot study of azithromycin and doxycycline efficacy in the treatment of prostate infection caused by Chlamydia trachomatis. Int J Antimicrob Agents 2004; 24: 188-191. (Pubitemid 38993701)
44. McCormack J, Bell S, Senini S, Walmsley K, Patel K, Wainwright C, et al., Daily versus weekly azithromycin in cystic fibrosis patients. Eur Respir J 2007; 30: 487-495. (Pubitemid 351182072)
45. Suzuki H, Ikeda K, Honma R, Gotoh S, Oshima T, Furukawa M, Takasaka T,. Prognostic factors of chronic rhinosinusitis under long-term low-dose macrolide therapy. ORL J Otorhinolaryngol Relat Spec 2000; 62: 121-127. (Pubitemid 30248562)
46. Wallwork B, Coman W,. Chronic rhinosinusitis and eosinophils: do macrolides have an effect? Curr Opin Otolaryngol Head Neck Surg 2004; 12: 14-17. (Pubitemid 38130697)
47. Haruna S, Shimada C, Ozawa M, Fukami S, Moriyama H,. A study of poor responders for long-term, low-dose macrolide administration for chronic sinusitis. Rhinology 2009; 47: 66-71.
48. Harvey RJ, Wallwork BD, Lund VJ,. Anti-inflammatory effects of macrolides: applications in chronic rhinosinusitis. Immunol Allergy Clin North Am 2009; 29: 689-703.